Design Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DSGN and other ETFs, options, and stocks.About DSGN
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.
CEOPratik Shah
CEOPratik Shah
Employees54
Employees54
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2017
Founded2017
Employees54
Employees54
DSGN Key Statistics
Market cap545.71M
Market cap545.71M
Price-Earnings ratio-8.06
Price-Earnings ratio-8.06
Dividend yield—
Dividend yield—
Average volume327.66K
Average volume327.66K
High today$9.80
High today$9.80
Low today$8.82
Low today$8.82
Open price$9.06
Open price$9.06
Volume161.85K
Volume161.85K
52 Week high$10.31
52 Week high$10.31
52 Week low$2.60
52 Week low$2.60
Stock Snapshot
The current Design Therapeutics(DSGN) stock price is $9.57, with a market capitalization of 545.71M. The stock trades at a price-to-earnings (P/E) ratio of -8.06.
On 2026-01-14, Design Therapeutics(DSGN) stock moved within a range of $8.82 to $9.80. With shares now at $9.57, the stock is trading +8.5% above its intraday low and -2.3% below the session's peak.
Trading activity shows a volume of 161.85K, compared to an average daily volume of 327.66K.
Over the past 52 weeks, Design Therapeutics(DSGN) stock has traded between a high of $10.31 and a low of $2.60.
Over the past 52 weeks, Design Therapeutics(DSGN) stock has traded between a high of $10.31 and a low of $2.60.
People also own
Based on the portfolios of people who own DSGN. This list is generated using Robinhood data, and it’s not a recommendation.